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alter the normal gelation time of the HyA hydrogels. In contrast to the stiff
agarose hydrogel, HyA hydrogels were relatively soft and slightly sticky.
In all hydrogel constructs, cells appeared spherical and more than 70% of
cells remained viable at 24 hrs after encapsulation, regardless of seeding
density (Fig. 1). Long term cell viability and proliferation were analyzed in
HyA-2 constructs at two cell densities. The viability of encapsulated cells
remained above 80-90% at low density, while it decreased to 60% at high
density over the 14 days culture duration (Fig. 2). No cell proliferation
was observed in the cell/HyA-2 constructs (Fig. 3). The number of hMSCs
present in the HyA-2 hydrogel remained unchanged with culture duration
at the lower seeding density, but decreased signiﬁcantly at higher density
(Fig. 3).
Figure 1. Viability of encapsulated hMCSs in four different hydrogels at two seeding den-
sities.
Figure 2. Viability of encapsulated hMCSs in HyA-2 at two seeding densities.
Figure 3. Proliferation of encapsulated hMSCs in HyA-2 during 14 days culture.
Conclusions: In this study, we evaluated the cellular response of hM-
SCs to three novel hyaluronan hydrogel formulations. Our initial results
demonstrated that the HyA hydrogels have the capacity to encapsulate
adult human stem cells without altering the intrinsic gelation time. All
hydrogels supported cell survival over an extended culturing period. Stem
cells regained their 3-D phenotype and appeared to switch from the
proliferating to differentiation state. The in situ, crosslinking capacity of
these HyA hydrogels may allow for the preparation of cell/gel mixture ex
vivo for subsequent delivery to a desired location where the crosslinking
process can be completed. Future studies will include evaluation of cell
differentiation in the hydrogel, secretion of cytokines from encapsulated
cells, and cell release from the hydrogel construct. Results from these
studies will shed light on the suitability of these HyA hydrogels as a cell
delivery carrier into targeted disease sites or tissue repair applications.
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Purpose: Mesenchymal Stem cells (MSCs) are useful multipotent stem
cells that are found in many tissues. Due to important ethic and safety
limitations for clinical use of pluripotent embryonic stem cells, MSCs are
predominantly used in human clinical assays. While MSCs can usually be
isolated from adults via bone marrow aspiration (BM-MSCs), MSCs derived
from the discarded umbilical cord, more precisely from Wharton’s jelly,
offer a low-cost and pain-free collection method of MSCs that may be cryo-
genically stored. Moreover, the feature of Wharton’s jelly MSCs (WJ-MSCs)
is intermediate between embryonic and adult MSCs. Brieﬂy, compared to
adult stem cells, they show an increased telomerase activity and compared
to embryonic stem cells, they have a lower rate of DNA lesions after cell
division. These properties are extremely favorable for considering them
for tissue engineering purpose. However, culture expansion of MSCs is a
prerequisite, since high absolute numbers of stem cells are required to
reach a clinical dose. Thus, the aim of this study was to characterize these
WJ-MSCs during monolayer expansion (from P0 to P10), under normoxia
or hypoxia conditions.
Methods: With the consent of the parents, fresh human umbilical cords
were obtained from full-term births, aseptically stored in sterile saline and
processed within 6 hours from partum to obtain the WJ-MSCs. Individual
UC components were dissected, diced into 1-2 mm3 fragments, and aligned
in explant cultures from which migrating cells were isolated by scraping
until reaching P10 in both normoxia and hypoxia cultures. Stem cells were
expanded using α-MEM 10% fetal calf serum (FCS) based media. For each
culture conditions, characterization was performed, at each passage, at two
levels: cellular level (cell morphology, immunophenotyping) and functional
level (differentiation potential and metabolic activity).
Results: We found that normoxia or hypoxia conditions inﬂuenced
metabolic activity of MSCs and population doubling time. Moreover,
whatever culture conditions, we observed, at early passages, modiﬁcations
of cell morphology suggesting the possible presence of cellular subpopu-
lations. Using ﬂow cytometric analysis, our data revealed that WJ-MSCs
express matrix receptors (CD44, CD166, CD90, CD271) and integrin markers
(CD29) but not hematopoietic lineage markers (CD34, CD45, HLA-class II).
Interestingly, these cells also express signiﬁcant amounts of mesenchy-
mal stem cell markers (SH2, SH3). Finally, individual WJ-MSCs could be
selectively differentiated into osteoblasts, chondrocytes, and adipocytes.
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Purpose: Most efforts performed to repair injuries of the articular cartilage
focus on the limitations of this tissue to heal injuries and how to promote
vascularization. A current challenge is to avoid generation of a ﬁbro
cartilaginous tissue that does not mimic hyaline articular cartilage. The
transplantation of mesenchymal stem cells (MSCs) has been suggested as
an alternative therapeutic approach for treatment of cartilage defects.The
aim of this study was to evaluate the effects of both N- and C-terminal
fragments of PTHrP to promote chondrogenesis using BM-MSCs cultured
on pure equine type I collagen supports.
Methods: MSCs were isolated from human BM stroma and were expanded
in monolayer cultures. BM-MSCs were characterized by ﬂow cytometry
using hematopoietic and MSC markers. At the 3-4th passage, BM-MSCs
were cultured on 1×1cm2 collagen supports, pre-treated or not with PTHrP
